Skandinaviska Enskilda Banken (SEB)
MNTA

Skandinaviska Enskilda Banken (SEB)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-76,923
Closed -$4.04M – 1192
2020
Q3 		$4.04M Buy
76,923
+62,323
+427% +$2.58M 0.03% 377
2020
Q2 		$486K Buy
+14,600
New +$465K ﹤0.01% 816

Skandinaviska Enskilda Banken (SEB)'s MNTA Position: Q4 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 76,923 shares — an estimated $4.04M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MNTA in Q2 2020 and held it in 2 quarters. The position peaked at $4.04M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 76,923 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $4.04M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 2 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Momenta Pharmaceuticals, Inc. position peaked at $4.04M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2020, filed 11 Feb 2021.